Status:

COMPLETED

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs

Lead Sponsor:

Rigshospitalet, Denmark

Conditions:

Covid19

Eligibility:

All Genders

16+ years

Phase:

NA

Brief Summary

This study aim to explore the optimal swap insertion length for mid-turbinate and nasopharyngeal samples. Our clinical trial took place at a Covid-19 test center in Copenhagen. Participants consisted ...

Eligibility Criteria

Inclusion

  • Referred for COVID-19 testing

Exclusion

  • Nose patology

Key Trial Info

Start Date :

March 7 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

March 8 2021

Estimated Enrollment :

109 Patients enrolled

Trial Details

Trial ID

NCT04840082

Start Date

March 7 2021

End Date

March 8 2021

Last Update

April 9 2021

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rigshospitalet

Copenhagen, Copenhagen East, Denmark, 2100

Optimal Length for Nasal Mid-turbinate and Nasopharyngeal Swabs | DecenTrialz